Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Daniel Ortisi
Stock Doctor’s commentary and golden rules
Daniel Ortisi of Stock Doctor gives us a detailed pre-market commentary on the results of popular small cap RPMGlobal Holdings Ltd (ASX: RUL). Is RUL share price a buy today? Mining advisory and software business RPM Global announced its 1H24 result which appears in line with management’s updated FY24 guidance. As RUL is passing the inflection point between loss making and profitability, we can see large variations in its bottom-line result.
A great day to be an equity investor with the S&P/ASX 200 (INDEXASX: XJO) Index up 1.65%
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +1.65% to 7,377.90. Markets @ Midday: Listen here at lunchtime or find all Market Matters Podcasts on Spotify.
XRF Scientific Limited (ASX:XRF) share price in focus
Daniel Ortisi of Stock Doctor shares a glimpse into the operations, drivers and potential risks of XRF Scientific Limited (ASX: XRF). Is XRF share price a buy today? Recently, our analyst team visited the executives of XRF Scientific Limited at their Melbourne precious metals labware manufacturing facility. This visit offered an insightful glimpse into the operations, drivers and potential risks of the business.
S&P/ASX 200 (INDEXASX: XJO) ends a solid week on the front foot
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +0.30% to 7,194.90. Markets @ Midday: Listen here at lunchtime or find all Market Matters Podcasts on Spotify. The market opened on the backfoot, down early, before rallying ~50pts into the close to finish at session highs, clearly a bullish tone to end the week with the solid intra-day move.
Wolfspeed, ST Microelectronics, and Arteris poised for growth
Darren Katz of Tamim Asset Management talks about the 3 unique semiconductor producers, namely, Wolfspeed Inc (NYSE: WOLF), STMicroelectronics NV (NYSE: STM) and Arteris Inc (NASDAQ: AIP), that have a bright share price future ahead in the share market. As we highlighted in last week’s article, semiconductors are a critical component in many of the leading-edge technologies that are transforming industries.
Endeavour Group Ltd (ASX:EDV) share price in focus
Drinks and hotels business Endeavour Group Ltd (ASX: EDV) recently held its Investor Day. The Analyst Team at Stock Doctor has provided an updated review of Endeavour Group, including our thoughts as to why the stock may be an undervalued opportunity for long-term investors.
Avoiding dividend yield traps - A comprehensive guide to protect your income
There are a lot of yield traps in the share market and understanding yield traps is an important step. Daniel Ortisi of Stock Doctor tells us how to avoid yield traps, with Peter Warren Automotive Holdings Ltd (ASX: PWR), Telstra Group Ltd (ASX: TLS), APA Group (ASX: APA), and Commonwealth Bank of Australia (ASX: CBA) as key examples. As an investor, it is crucial to differentiate attractive dividend-paying stocks and yield traps. What is a yield trap?
Rates hopes sends the share market higher: Treasury sinks on capital raise
Signs that US interest rates could remain on hold boosted the Australian share market on Friday, with the All Ordinaries (INDEXASX: XAO) and S&P/ASX 200 (INDEXASX: XJO) both gaining 1.1% with the energy sector the only detractor. The most interest rate sensitive sectors, being property, industrials and healthcare all gained strongly, adding more than 2% each, with Charter Hall Group (ASX: CHC) and Scentre Group (ASX: SCG) adding 3.7% and 4.5% as lower rates mean stronger property valuations.
Stocks chalk up 4-day rally as bond yields fall
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +1.14% to 6978.20. Markets @ Midday: Listen here at lunchtime or find all Market Matters Podcasts on Spotify.
What’s the story behind Trajan Group Holdings Ltd (ASX:TRJ)?
Members of the Stock Doctor analyst team attended the Trajan Group Holdings Ltd (ASX: TRJ) inaugural shareholder day on Monday the 30th of October. This gave us an opportunity to further understand the business, meet management and visit its manufacturing facility in Ringwood, Melbourne. Trajan is not currently a star stock as it doesn’t meet our criteria under Golden Rules 2&3.
What is the Nasdaq Composite Index?
The Nasdaq Composite Index is a stock index that reflects the changes of the NASDAQ stock market. Nasdaq-listed companies cover all new technology industries, including software and computers, telecommunications, biotechnology, retail and wholesale trading.
The Match Out: Equities unchanged though inflation continues to bite
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished down -0.038% to 6854.30. Markets @ Midday: Listen here at lunchtime or find all Market Matters Podcasts on Spotify. The market was relatively strong early on, supported by solid overnight gains in the US and most commodity markets, however, the music stopped at 11.30m as local inflation data came in higher than expected.
Lynas Rare Earths Ltd (ASX:LYC) licence extension: What will change?
Our team at Stock Doctor have been providing bottom-up, high-quality equity research to self-directed Australian investors for decades and we’re offering you FREE access to our platform for 14 days. We are currently in the trenches of reporting season and will be providing tons of content for those investors who are struggling to find opportunities in this market.
What is a fund?
Fund refers to an investment product in which a fund company collects the money of many investors and makes a variety of investments to achieve returns according to certain rules. The profits or risks obtained by the investment are shared by the investors in proportion to their investment. So with a fund, you give your money to a fund manager who helps you divide your investment assets. What are the specific funds? In terms of purchase, funds are divided into public and private funds.
Finding opportunities in a falling market
Rising bond yields, oil prices, and now heightened geopolitical tensions in the Middle East have seen equity markets pull back. The S&P/ASX 200 (INDEXASX: XJO) is effectively flat year-to-date, giving up gains of close to 8% seen in July. Navigating the volatility The team at Stock Doctor has always placed company fundamentals above macroeconomic factors when constructing our Star Growth and Income universe.
The Match Out: Energy and Resources weigh on the index as traders wait on the Fed
If you’re reading this article on Rask, chances are, you’re in the market for passive income. Whether you’re in retirement or growing your assets — income matters! So how’s this: our team at Market Matters has delivered a 15.3% return from our Income Portfolio*. How does that happen? I can tell you, it’s not by chance. In our brand-new free investing report — we break down “the good, the bad & the ugly”, reviewing the standout ASX income stars, as well as analysing our underachievers.
Why We’re Bullish on Resmed - A Deeper Dive into GLP-1 Treatments
Our team at Stock Doctor have been providing bottom-up, high-quality equity research to self-directed Australian investors for decades and we’re offering you FREE access to our platform for 14 days. We are currently in the trenches of reporting season and will be providing tons of content for those investors who are struggling to find opportunities in this market.
The Match Out: ASX 200 climbs on resources
If you’re reading this article on Rask, chances are, you’re in the market for passive income. Whether you’re in retirement or growing your assets — income matters! So how’s this: our team at Market Matters has delivered a 15.3% return from our Income Portfolio*. How does that happen? I can tell you, it’s not by chance. In our brand-new free investing report — we break down “the good, the bad & the ugly”, reviewing the standout ASX income stars, as well as analysing our underachievers.
3 factors driving stock returns
The next 18 months will be very different to the past 18 months The past year saw several significant macro events such as a banking crisis, a debt showdown, war and decoupling. Ultimately, these events shifted the outlooks for overall demand and supply, in turn having impacts on the three drivers of equity market returns: the profit outlook, interest rate outlook and risk premiums.
Uncover Opportunities After Reporting Season with Stock Doctor
Having high-quality datasets across all 2000 stocks on the ASX means that we can identify opportunities early on in a company’s life cycle by using the filtering tools on Stock Doctor. Take for example, Rea Group Ltd (ASX: REA), Stock Doctor first flagged Rea Group back in 2005 when it passed our quantitative filters at $2.27 per share. Other success stories include CSL Limited (ASX: CSL) in 1996 (yes … Stock Doctor is really that old) and Pro Medicus Limited (ASX: PME) in 2006.
All Ordinaries (INDEXASX:XAO) sinks despite GDP data beat
The local share market weakened again on Wednesday, with the All Ordinaries (INDEXASX: XAO) down 0.7% and the S&P/ASX 200 (ASX: XJO) falling 0.8% as seven sectors fell by more than 1%. The rare highlight was the energy sector, which gained 1% on the back of the oil price surging above US$90 per barrel and boosting the likes of Woodside Energy Group Ltd (ASX: WDS), up 1.4%, and Santos Ltd (ASX: STO), which finished 1% higher.
2 top ASX lithium shares we'd buy now
In this article, I pull apart 2 top ASX lithium shares we would buy now. Here goes… Reporting season has come and gone, and weāre sharing our key takeaways within the lithium sector. Record profits from the likes of Pilbara Minerals Ltd (ASX: PLS) and IGO Ltd (ASX: IGO) led to mountains of cash sitting on balance sheets, and outsized dividends returned to shareholders.
Will weight-loss wonder Ozempic kill Resmed CDI (ASX:RMD) shares?
It’s rare to see a high-quality, growing, blue-chip healthcare share fall 26%, but that’s just what happened to Resmed CDI (ASX: RMD) after its Q4 2023 financial results. ResMed is a world leader in devices and technology for the treatment of sleep apnea. It sells products and software to customers all around the world. It has done for many years… So is ResMed’s share price an allergic reaction to Ozempic, or something else? Is ResMed fundamentally damaged?
Is the Propel Funeral Partners Ltd (ASX:PFP) share price a takeover target?
After the recent private equity takeover of funeral home operator InvoCare Limited (ASX: IVC) the team at Stock Doctor takes a closer look at the industry‚Äôs second-largest player ‚Äď Propel Funeral Partners Ltd (ASX: PFP). What is Propel? Propel Funeral Partners own funeral homes, cemeteries, crematoria and related assets across Australia and New Zealand, providing a broad range of services and products across the death care industry.
Own Pilbara Minerals (ASX:PLS) shares? You need to read this
Sociedad Quimica y Minera de Chile (NYSE: SQM) is the world’s second-largest producer of lithium chemicals. Its 2Q23 report stunned the market by missing analyst profit expectations by ~20%, sending its shares lower. The miss was driven almost entirely by lower-than-expected realised lithium prices, as the market has experienced a significant level of volatility in recent months.
On The Couch with Chris Gale & Henry Jennings
Get Ready to Navigate the ASX Reporting Season! Want to finish the investing year on a high note? If you enjoyed this article, join us for a FREE August Reporting Season Webinar on Thursday, August 17 th at 12:45pm AEST. Gain valuable insights to identify potential winners for future gains, while avoiding portfolio-harming losers.
GUD Holdings Limited (ASX:GUD) share price has soared - now what?
Over the past 5 days, the GUD Holdings Limited (ASX: GUD) share price has jumped 12.5%. But that’s no surprise to the team at Stock Doctor. Analyst Daniel Ortisi explains why this week’s news means for GUD shareholders. When GUD Holdings Limited’s (ASX: GUD) management announced the sale of Davey Water, we noted in our article published on Rask Media (just last week!) that there were two key positive comments made by management that were good for shareholders.
Cochlear Ltd (ASX:COH) share price pops: our Cochlear thesis
The Cochlear Limited (ASX: COH) share price bounced dramatically higher this week following a bumper report. But is the Cochlear share price looking a little expensive? Stock Doctor’s Daniel Ortisi weighs in. Hearing solutions provider Cochlear Limited (ASX: COH) has bucked the trend of ASX healthcare stocks missing earnings expectations, including Resmed CDI (ASX: RMD), CSL Limited (ASX: CSL) and Capitol Health (ASX: CAJ).
CBA share price jumps: what you really need to know about the Commbank result
This week, the Commonwealth Bank of Australia (ASX: CBA) share price jumped after reporting results. But was it really a good result for CBA shareholders? Stock Doctor’s Daniel Ortisi takes a deep look. The Commonwealth Bank of Australia (ASX: CBA) reported a record profit result of $10.2b for FY23, driven by rising net interest margins as the country’s largest financial institution continues to pass through mortgage hikes at a faster pace than deposit rates.
Arena REIT No 1's (ASX:ARF) FY23
General Financial Advice warning The information on this website is general financial advice only. That means, the advice does not take into account your objectives, financial situation or needs. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product.
Suncorp Group Ltd’s (ASX:SUN) Disappointing Dividend Overshadows Their Profit Growth
General Financial Advice warning The information on this website is general financial advice only. That means, the advice does not take into account your objectives, financial situation or needs. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product.
Why GUD's divestment is good for the GUD Holdings Limited (ASX:GUD) share price
Ā General Financial Advice warning Ā The information on this website isĀ general financial advice only. That means, the advice does not take into account your objectives, financial situation or needs. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product.
Rio Tinto Ltd (ASX:RIO): Why we exited our RIO shares
From 2,000 to 200 ASX stocks with “exceptional financials” If you liked my article, you’ll love this… Thanks to our partnership with Rask, you can get FREE access to our equity research at Stock Doctor. What does that mean? Let our expert research team at Stock Doctor guide you to finding the best stocks this ASX reporting season with immediate and free access to our ASX equity research, including full coverage of our Star Stocks.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Daniel
Contact Daniel, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack